ROS1 mutation and treatment with crizotinib in a 30-year old Caucasian woman with stage IV non-small cell lung cancer/adenocarcinoma and complete remission-Reference-Cited by-同舟云学术

ROS1 mutation and treatment with crizotinib in a 30-year old Caucasian woman with stage IV non-small cell lung cancer/adenocarcinoma and complete remission

Published:2014-08-25 Issue:5 Volume:5 Page:455-459
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Blaukovitsch Markus¹,Hofer Johann¹,Hutarew Georg²,Müllauer Leonhard³,Ingrid Simonitsch-Klupp³,Studnicka Michael¹

Affiliation:

1. Department of Pulmology; SALK; Medical University of Salzburg; Salzburg Austria

2. Department of Pathology; SALK; Medical University of Salzburg; Salzburg Austria

3. Department of Pathology; AKH Wien; Medical University of Vienna; Wien Austria

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1759-7714.12106/fullpdf

Reference12 articles.

1. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;Kwak;N Engl J Med,2010

2. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

3. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

4. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib;Pao;Proc Natl Acad Sci U S A,2004

5. Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population;Rodig;Clin Cancer Res,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-smoking woman with adenocarcinoma of the lung, IV stage with ROS1 mutation and acquired thrombophilia;Journal of Pulmonology and Respiratory Research;2021-08-04

2. A comprehensive study on the oncogenic mutation and molecular pathology in Chinese lung adenocarcinoma patients;World Journal of Surgical Oncology;2020-07-16

3. Crizotinib;Adverse Events and Oncotargeted Kinase Inhibitors;2017